Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAS2R10 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | DENND6A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SOCS7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TUFM | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | UBE2F | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NPM2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF286A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | TRIP10 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | ALMS1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ADA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |